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Activation of the kallikrein-kinin system in hemodialysis: Role Since the original report of Poothullil et al in 1975
of membrane electronegativity, blood dilution, and pH. [1], numerous studies have been published that describe
Background. The kallikrein-kinin system activation by con- hypersensitivity reactions (HSR) during hemodialysis.
tact with a negatively charged surface has been promulgated These HSR, also reported as first use syndrome, immedi-to be responsible for hypersensitivity reactions. However, to
ate hypersensitivity reactions or anaphylactoid reactions,explain the low frequency and heterogeneity of hypersensitivity
occur within the first 10 minutes after connection of thereactions, we hypothesized that not only the electronegativity
venous line. They are observed with all types of dialysisof the membrane, but also other physicochemical parameters
could influence the activation of the contact phase system of membranes, low or high flux, natural or synthetic [2–6].
plasma assessed by the measurement of kallikrein activity and Their frequency is quite low at 3.3 per 1000 patients per
bradykinin concentration. year with hollow fiber dialyzers and 0.3 per 1000 patients
Methods. Plasma kallikrein activity using chromogenic sub- per year with flat sheet membranes [7]. Several etiologicstrate (S2302) and plasma bradykinin concentration (enzyme
factors have been implicated as triggers of dialysis-immuno assay) were measured during the perfusion of human
induced HSR: ethylene oxide, toxic leachables, acetateplasma (2.5 ml/min) through minidialyzers mounted with six
dialysate, bicarbonate dialysate contamination and reusedifferent membranes [polyacrylonitrile (PAN) from Asahi
(PANDX) and from Hospal (AN69), polymethylmethacrylate procedure [reviewed in 8]. Different pathophysiological
(PMMA) from Toray, cellulose triacetate (CT) from Baxter, mechanisms have also been hypothesized, such as activa-
cuprophane (CUP) from Akzo and polysulfone (PS) from Fre- tion of the complement system [9], release of histamine
senius].
and, more recently, the release of bradykinin (BK). TheResults. A direct relationship was shown between the elec-
proposal that BK release may be involved in HSR re-tronegativity of the membrane assessed by its zeta potential
sulted from the observation of an increased frequencyand the activation of plasma during the first five minutes of
plasma circulation. With the AN69 membrane, the detection of HSR in patients dialyzed using the AN69 membrane,
of a kallikrein activity in diluted plasma but not in undiluted which presents a negatively charged surface, while they
samples confirmed the importance of a protease-antiprotease simultaneously received angiotensin-converting enzyme
imbalance leading to bradykinin release during the first five (ACE) inhibitors [6, 10].minutes of dialysis. With PAN membranes, the use of citrated
Bradykinin is a powerful proinflammatory peptide re-versus heparinized plasma and the use of various rinsing solu-
leased from its precursor high molecular weight kinino-tions clearly show a dramatic effect of pH on the kallikrein
gen (HMWK) by plasma kallikrein during the activationactivity and the bradykinin concentration measured in plasma.
Finally, increasing the zeta potential of the membrane leads of plasma in contact with a negatively charged surface.
to a significant increase of plasma kallikrein activity and brady- Bradykinin is a short-lived peptide due to its rapid me-
kinin concentration. tabolism by different peptidases, in particular ACE [11].
Conclusions. Our in vitro experimental approach evidences
However, the definition of the physicochemical factorsthe importance of the control of these physicochemical factors
potentially involved in the activation of the contact sys-to decrease the activation of the contact system.
tem of plasma during hemodialysis have been poorly
documented.
The purpose of this in vitro study is to define the influ-Key words: dialysis membrane, bradykinin, contact system of plasma,
angiotensin-converting-enzyme inhibition, dialysate. ence of three important physicochemical factors that are
potentially responsible for the activation of the plasmaReceived for publication April 9, 1998
contact system during hemodialysis: the electronegativityand in revised form September 30, 1998
Accepted for publication October 3, 1998 of the dialysis membrane, the dilution of plasma and the
pH of the diluted blood. The activation of the contact 1999 by the International Society of Nephrology
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Table 1. Characteristics of polyacrylonitrile (PANDX and AN69), purchased from BASF (Ludwigs Hafen am Rhein, Ger-
cuprophane (CUP), cellulose triacetate (CT), many). The electrometer model 517 E was from Keithleypolymethylmethacrylate (PMMA) and
Int. (Cleveland, OH, USA) and the plate reader iEMSpolysulfone (PS) minidialyzers
was from Life Science International (Cergy Pontoise,PANDX AN69 CUP CT PMMA PS
France). All other reagents of analytical grade were ob-
Effective length cm 12 18 18 12 12 18 tained from Prolabo (Lyon, France).Number of fibers 170 170 170 170 170 170
Effective surface area cm2 163 231 207 128 115 195
In vitro extracorporeal circuit (ECC)Contact time secondsa 25 34 27 15 13 24
Internal diameter of The same experimental approach was used for testing
fibers lm 240 240 215 200 180 203
each physicochemical parameter. For the rinsing phase,
a Contact time of plasma or blood with the dialysis membrane tested depends the saline solution (NaCl 0.15 m) circulated successivelyon the length and diameter of fibers
through the blood and dialysate compartments at a flow
rate of 5 ml/min for 10 minutes under hemodynamic
conditions identical to those of clinical use. Plasma was
then passed through the minidialyzer at a flow rate ofsystem of plasma will be assessed by the measurement
2.5 ml/min for 30 minutes. At the outlet, samples wereof both kallikrein activity and BK concentration.
collected at predetermined times for the quantitation of
immunoreactive BK. For the measurement of kallikrein
METHODS activity, plasma was diluted (1/20) with saline prior to
Material circulation through the hemodialyzer and was collected
at the outlet of the minidialyzer after 4, 6 and 10 minutesMembranes and minidialyzers. Six commercially avail-
of circulation.able dialysis membranes were tested: polyacrylonitrile
(PAN) (PANDX, Asahi, Japan and AN69, Hospal Cobe,
Measurement of plasma kallikrein activityFrance), polymethylmethacrylate (PMMA) (BK series,
The method used for kallikrein activity measurementToray, Japan), cuprophane (CUP) (Akzo, Germany),
was a modification of that previously described by DeLacellulose triacetate (CT) (Baxter, USA) and polysulfone
Cadena, Scott and Colman for plasma prekallikrein [12].(PS) (Fresenius, Germany). AN69 ST (Hospal Cobe,
Fifty microliters of the diluted plasma were incubatedFrance), a membrane still at the developmental stage,
for 10 minutes at 378C in the presence of 50 ml of Triswas also tested. The hollow fiber minidialyzer (Hospal
buffer (50 mm, pH 7.9) mixed with 100 ml of chromogenicR&D Int.) used in the experiments was developed as a
substrate, S 2302, at a final concentration of 0.7 mmol/small scale model (1/50) of a standard hollow fiber dia-
liter. The incubation was conducted in 96 well microplateslyzer. The characteristics of the minidialyzers employed
(Nunc) and the enzymatic reaction was stopped by addingin the current experiments are summarized in Table 1.
100 ml of acetic acid (8.7 mol/liter). Absorbances werePlasma samples. Standard citrate (0.11 m) or heparin
read at 405 nm with an iEMS reader and plasma kalli-(5 IU/ml) anticoagulated plasma units were used for
krein activities were calculated from a calibration curveall in vitro experiments. Fresh plasma pack units from
incubated in parallel with the samples. The calibrationhealthy donors were obtained from the Etablissements
curve was constructed using serial dilutions (1/8, 1/12.5,
de Transfusion Sanguine, Lyon, France. For kallikrein 1/25, 1/50 and 1/100) of a stock solution (600 U/liter) of
evaluation, citrated plasma was diluted 1/20 with saline commercially available purified human kallikrein in 1/20
before circulation through the minidialyzers. However, diluted citrated plasma. The detection limit was ,5
for BK measurements, heparinized and citrated plasma U/liter and the intra- and interassay coefficients of varia-
were undiluted. The pH of citrated and heparinized tion were ,5 and ,8%, respectively, for an activity of
plasma was 7.1 6 0.1 and 7.4 6 0.1, respectively. 6, 24 and 72 U/liter.
Reagents. Saline (NaCl, 0.15 m) and sodium bicarbon-
ate (0.17 m) were obtained from Aguettant (Lyon, France). Determination of plasma bradykinin
Chromogenic substrate (S 2302) and purified human Undiluted plasma (1 ml) was collected at the outlet
plasma kallikrein were purchased from Biogenic (Maurin, of the minidialyzer in cold absolute ethanol (4 ml). After
France). Alkaline phosphatase-labeled Fab fragments careful homogenization and incubation at 48C, the etha-
antidigoxigenin and p-nitrophenylphosphate were ob- nolic extract was centrifuged (1075 3 g, 15 min). The
tained from Boehringer Mannheim (Mannheim, Ger- supernatant was evaporated to dryness using a Speed
many). C8-silica columns were supplied by Waters (Mil- Vac system before the extraction step. The ethanolic
ford, MA, USA). The Speed Vac Concentrator was from residues were resuspended in 2 ml of cold trifluoroacetic
Savant (Farmingdale, NY, USA) and the gazometric an- acid (TFA) 0.1% in water, and centrifuged (1075 3 g,
alyzer ABL 5 pH meter from Radiometer Laboratory 15 min). The clear supernatant (1 ml) was loaded on a
column containing C8-silica (100 mg) conditioned by(Neuilly Plaisance, France). Polyethyleneimine (PEI) was
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Table 2. Comparative representation of zeta potential (surfacesuccessive washing with acetonitrile (3 ml) and TFA
electronegativity), plasma kallikrein activity and bradykinin (BK)
0.1% (2 ml). After a washing step with 3 ml of TFA concentration measured for the six dialysis membranes tested
0.1%, bound kinins were eluted with 2 ml of an acetoni-
Zeta potential Plasma kallikrein BK generation
trile (30%)/TFA 0.1% solution. This eluate was evapo- Membrane mV U/liter fmol /ml
rated to dryness in a Speed Vac system. The residue was AN69 27065 60615 32100 (26500–41200)
dissolved in 1 ml of 50 mm Tris-HCl buffer, pH 7.4, PANDX 26064 80620 28983 (22600–36150)
PMMA 22562 1065 130 (50–250)containing 100 mm NaCl and 0.05% Tween-20. Competi-
CT 22062 ,5 65 (25–100)
tive enzyme immunoassay (EIA) was employed to quan- CUP 21061 ,5 78 (25–150)
PS 2561 ,5 62 (25–120)titate BK [13]. This assay used highly specific polyclonal
Kallikrein and BK were measured respectively in diluted and undiluted ci-rabbit IgG raised against the carboxy-terminal end of
trated plasma after 5 minutes of circulation through the different minidialyzers.BK, digoxigenin-labeled BK as tracer, and alkaline phos- For both zeta potential and plasma kallikrein, each value represents the mean 6
sd of 6 determinations. For BK, mean values of six determinations are repre-phatase-labeled Fab fragments antidigoxigenin to detect
sentated with lower and upper values between parentheses. The one-way ANOVA
and quantitate the immune complexes. Each sample was shows that means of zeta potential, plasma kallikrein activity and BK concentra-
tion are statistically different (P , 0.001) for the AN69 and PANDX membranes.measured in triplicate. On a molar basis, the polyclonal
anti-BK-purified IgG exhibited no cross-reactivity with
des-Arg9-BK. Typical calibration curves were character-
ized by a half-maximal saturation value of 0.78 pmol/ml.
Influence of pH of the rinsing solution
The influence of pH on the activation of prekallikreinExperimental protocols
and the release of BK was studied using phosphate andCharacterization of electronegativity of the membranes.
bicarbonate buffer solutions. Phosphate buffers wereThe electronegativity of each dialysis membrane was
prepared according to the following formulas: pH 5 5assessed from its zeta potential measured directly in the
0.8 ml Na2HPO4·H2O (11.9 g/liter) mixed with 99.2 mlminidialyzer. The electrical potential, E, created by an
KH2PO4 (9.1 g/liter); pH 7 5 41.3 ml KH2PO4 (9.1 g/electrolyte (1022 m NaCl) streaming inside a dialyzer
liter) mixed with 58.7 ml Na2HPO4·H2O (11.9 g/liter).may be measured between two Ag/AgCl electrodes using
All pH values were determined with gasometric analyzerspecial connectors on blood headers. When the pressure
ABL5. The solutions were used to rinse the blood anddrop, DP, due to the streaming is measured between the
dialysate compartments before commencing in vitrosame two connectors, the streaming potential E/DP is
plasma circulation. The results obtained were comparedrelated to the zeta potential z according to the Helm-
with those obtained following classical saline rinsing.holtz-Smoluchowsky equation [14]:
(E/DP) 5 (ze/4phl) Statistical analysis
All results were expressed as means 6 sd. Statisticalwhere e and h are the dielectric constant and the dynamic
analysis of data was performed with an analysis of vari-viscosity of the electrolyte, respectively, and l is the
ance (ANOVA) followed by a post hoc Scheffe´s test fortrue conductivity of the system in equilibrium with the
multiple comparisons between groups. A P , 0.05 waselectrolyte as obtained from resistance measurements
considered as significantly different.using a Wheatstone bridge with alternating current. Ar-
bitrarily, the zeta potential is expressed in negative val-
ues for negatively charged surfaces.
RESULTS
Zeta potential of dialysis membranes, kallikreinReduction of surface electronegativity charges of
activation and bradykinin releaseAN69 dialysis membrane
The zeta potentials of the different dialysis membranesTo reduce the surface electronegative charge of the
are presented in Table 2. Polyacrylonitrile membranesAN69 membrane, minidialyzers constructed using this
(AN69 and PANDX) exhibited the highest surface electro-membrane were rinsed with a polycationic saline solution
negativity (270 6 5 mV and 260 6 4 mV, respectively)(PEI, 40 mg/liter). This solution was allowed to circulate
and cuprophane and polysulfone membranes the lowestfor two minutes (flow rate 5 4 ml/min) resulting in the
(210 6 1 mV and 25 6 1 mV, respectively), while zetaAN69 membrane being coated with 5 mg PEI per m2.
potentials were intermediate for polymethylmethacrylateMinidialyzers containing the modified membrane, which
and cellulose triacetate membranes (225 6 2 mV andwas named AN69 ST (Surface Treated), were used to
220 6 2 mV, respectively).evaluate the influence of the PEI on the zeta potential,
kallikrein and bradykinin release as described above. Kallikrein activities, as measured in diluted citrated
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Fig. 1. Effects of plasma dilution on the kallikrein activity measured
Fig. 2. Kallikrein activity measured in diluted plasma equilibrated atin undiluted (j) and 1/20 diluted (d) plasma after a 20 min circulation
four different pH values after a four (h), six (j) and 10 ( ) minuteon AN69 membrane. Each point represents the mean 6 sd of measure-
circulation through AN69 minidialyzers. Results are mean 6 sd for N 5 6ments on 6 different plasmas, in both experimental conditions (***P ,
different experiments. **P , 0.01 for pH 7.1 vs. pH 7.4, 7.6 and 7.8 at0.001 vs. undiluted plasma).
every contact time; †P , 0.05 for pH 7.4 vs. pH 7.6 and 7.8 at 6 and 10 min.
plasma after a five-minute circulation in the different
minidialyzer systems, are also presented in Table 2. Kalli- Contact phase activation and bradykinin release by
krein activity associated with polysulfone, cuprophane PAN dialysis membranes
and cellulose triacetate membranes was below the detec- Effect of pH. To test the effect of pH on kallikrein
tion limit of the assay. Significantly higher activities were activity, the pH of the 1/20 dilution of citrated plasma
recorded for polyacrylonitrile (AN69 and PANDX) and (pH 5 7.1) was adjusted to 7.4, 7.6 and 7.8 by dropwise
polymethylmethacrylate membranes. addition of 0.1 n NaOH. Kallikrein activity was measured
Table 2 shows that BK production was very low for after circulation times of 4, 6 and 10 minutes. As shown
cellulose triacetate, cuprophane, and polymethylmetha- in Figure 2, maximal kallikrein activity (47 6 16 U/liter)
crylate membranes and highest for polyacrylonitrile was measured at pH 7.1. The activity progressively de-
(AN69 and PANDX) membranes. An evident relation- creased as the pH of the diluted plasma was gradually
ship between the zeta potential, plasma kallikrein activ- increased until it was undetectable at a pH of 7.8. The
ity and concentration of immunoreactive BK was appar-
effect of pH on the release of immunoreactive BK was
ent: The more electronegative the dialysis membrane
measured using two experimental approaches. First, un-and the greater its potential to activate prekallikrein, the
diluted citrated plasma (pH 7.1) was circulated through agreater was the release of BK.
PAN membrane (AN69) minidialyzer previously rinsed
with either a saline solution (pH 6.0), a phosphate bufferEffect of plasma dilution on the activation of
(pH 5.0 or pH 7.0) or a sodium bicarbonate buffer (pHplasma prekallikrein
8.0). In each case, BK was measured after a five-minuteKallikrein activity was measured in the AN69 minidia-
circulation of plasma. Table 3 shows that BK releaselyzer effluent after different circulation times (0, 5, 10 and
depends on the pH of the rinsing solution. Progressively20 min). Figure 1 illustrates that the enzymatic activity of
decreasing the pH of the rinsing agent resulted in aundiluted plasma was below the limit of detection (,5
progressive increase in BK release from 21.6 to 97.9U/liter). However, when 1/20 diluted plasma was circu-
pmol/ml. Minimal values (70 to 440 fmol/ml) were ob-lated in the minidialyzer, kallikrein activity was detect-
tained for pH 8. In a second series of experiments, hepa-able with peak activity (63 6 18 U/liter) being measured
rinized plasma (pH 7.4) was used instead of citratedat 5 min. Thereafter, a progressive decrease in activity
plasma. Table 3 shows that increasing the pH of thewas observed (38 6 11 U/liter) at 10 minutes and (19 6 6
U/liter) at 20 minutes. rinsing solution from 5 to 8 for buffered solution (phos-
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Table 3. Effect of the pH and the nature of rinsing solutions on bradykinin (BK) generation after a five-minute circulation
of plasma in AN69 minidialyzers
Rinsing solution
BK generation
Blood compartment Nature pH Buffer capacity fmol /ml
Citrated plasma (pH 7.1) Phosphate 5 yes 97867 (60600–150000)
Phosphate 7 yes 21633 (6900–36300)
NaHCO3 1.4% 8.0 yes 207 (70–440)
NaCl 0.9% 6.0 no 36975 (26500–51600)
Heparinized plasma (pH 7.4) Phosphate 5 yes 12568 (8500–15200)
Phosphate 7 yes 672 (400–1130)
NaHCO3 1.4% 8.0 yes 90 (50–130)
NaCl 0.9% 6.0 no 168 (30–421)
Each value represents the mean of six determinations. Lower and upper BK values are between parentheses. A two-way ANOVA shows an interaction (P ,
0.001) between the nature (citrated/heparinized) and the pH of the sample. For citrated plasma, mean concentration of BK measured at different pH are statistically
different (P , 0.001). For heparinized plasma, the statistical difference (P , 0.001) was only observed after logarithm transformation; this observation can be
explained by the dispersion of the BK concentration. The mean BK concentration measured at pH 5, 7, and for NaCl rinsing solutions was different for both kinds
of blood samples. For pH 8, the release of BK was different between heparinized and citrated plasmas.
Table 5. Effect of rinsing of AN69 dialysis membrane withTable 4. Bradykinin (BK) concentrations measured after a
five-minute circulation of undiluted citrated plasma through polyethyleneimine (PEI) on zeta potential, kallikrein activity and
bradykinin (BK) concentration after a five-minute circulation ofminidialyzers made with membranes other than AN69
diluted or undiluted citrated plasma
Dialysis membrane BK generation fmol /ml
Zeta potential Plasma kallikrein Plasma BK
PAN DX 87967 (7030–135600) Membrane mV U/liter fmol /ml
PMMA 2807 (220–6700)
CT 5040 (420–13100) AN69 27065 60 615 32100 (26500–41200)
AN69 ST 2361 ,5 150 (30–450)CUP 2800 (300–5900)
PS 1173 (220–1900) For both zeta potential and plasma kallikrein, each value represents the mean 6
sd of six determinations. For BK, mean values of six determinations are repre-Each value represents the mean of three determinations. Lower and upper
sented with lower and upper values between parentheses. The means of zetaBK values are between parentheses. The mean concentration of BK for the five
potential, plasma kallikrein and BK are statistically different between AN69 andexperimental conditions was statistically different (ANOVA, P , 0.001). The
AN69 ST (P , 0.001).post hoc Scheffe´’s test showed no statistical difference between PS, CUP, PMMA
and CT membranes, which are significantly different from PANDX membrane
(P , 0.01).
physicochemical modification resulted in a significant de-
crease in the activation of citrated plasma as reflected byphate or bicarbonate) results in a decrease of BK genera-
a reduction in kallikrein activity and BK concentrationtion from 12568 to 90 fmol/ml. Moreover, using unbuf-
(Table 5).fered saline solution (pH 6.0), BK release is limited.
Bradykinin generation during in vitro extracorporeal
DISCUSSIONcircuit with the other dialysis membranes
Several clinical observations have suggested the possi-Minidialyzers containing the other five dialysis mem-
bility that the powerful proinflammatory peptide BK isbranes were rinsed with phosphate buffer, pH 5, and
involved in HSR associated with hemodialysis [5, 6, 17].used to quantitate BK release from plasma. With each
Surprisingly, only one study has clearly shown that plasmaof the membranes tested, immunoreactive BK could be
BK is significantly increased during HSR [15]. Followingmeasured after five minutes of circulation. Table 4 shows
the observation of a higher incidence of HSR in patientsthat the greatest release of BK was obtained with
treated with ACE inhibitors while undergoing dialysisPANDX, which is significantly different from polysul-
using AN69 membranes, Tielemans et al hypothesizedfone, cuprophane, cellulose triacetate and polymethyl-
that another factor(s) in addition to the electronegativitymethacrylate membranes for which there is no statistical
of the dialysis membrane could activate the contact systemdifference. In one experiment with a cellulose triacetate
of plasma, leading to the release of BK [16].membrane, a plasma BK concentration . 10 pmol/ml
In the present study, minidialyzers designed as 1/50was detected.
scale replicas of dialyzers were used to define the poten-
Influence of the reduction of the zeta potential of tial role of different physicochemical factors in the trig-
AN69: AN69 ST gering of the contact system. Normal human plasma was
allowed to circulate through these minimodules underIn situ coating of the AN69 membrane with PEI reduced
its zeta potential from 270 6 5 mV to 23 6 1 mV. This hemodynamic conditions identical to those used in clini-
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cal dialysis. Since the main clinical symptoms of HSR and bicarbonate dialysate to rinse dialyzers (different
types; pH 7.19 6 0.07, N 5 25) [19]. In fact, both factorsappear during the first minutes of hemodialysis, activa-
tion of the contact system was investigated during the have long been known to be responsible for the activa-
tion of HMWK during its purification from humanfirst 10 minutes of plasma circulation using two analytical
approaches. First, we measured plasma kallikrein activity plasma [20]. The use of solutions of well-defined buffered
pH (alkaline rinsing solution pH 7.8 or bicarbonate dialy-levels because these reflect the activation of plasma pre-
kallikrein by activated Hageman factor in contact with a sate pH 7.4), coupled with a chemically modified electro-
negatively charged membrane, could decrease the inci-negatively charged surface. As kallikrein activity is rapidly
neutralized by several plasma serine antiproteases, in dence of HSR and the triggering of the intrinsic pathway
of the coagulation [21] without affecting the dialysis per-particular C1 esterase inhibitor, we applied the method
previously described by DeLa Cadena et al for prekalli- formances of these membranes.
In conclusion, to our knowledge for the first time, wekrein to the quantitation of kallikrein in diluted plasma
[12]. Second, as a major consequence of the transforma- have clearly shown that the activation of the kallikrein-
kinin system, which is an important factor in the patho-tion of prekallikrein into kallikrein is its proteolytic activ-
ity on HMWK and the release of BK, we quantitated physiology of HSR, depends not only on the nature of
the dialysis membrane, but also on the control of thethis labile peptide after stabilization of the sample and
extraction, using a highly sensitive nonisotopic immuno- different physical and chemical factors evidenced in the
present paper. Although performed in vitro, our experi-assay [13] specific for the carboxy-terminal end of BK.
The results clearly show that the higher the kallikrein mental approach constitutes the basis for further investi-
gations in which we will define, in vivo, the influenceactivity in plasma, the higher the concentration of immu-
noreactive BK. of ACE inhibition and the importance of the different
metabolic pathways in the metabolism of BK on theUsing the same in vitro experimental approach, we
also observed that the circulation of plasma in contact development of HSR.
with a negatively charged surface (PAN membranes) leads
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